{"title":"2岁儿童脑室内霉菌感染提示曲霉病,临床结果成功","authors":"HCV Tulasi Ram , Madhivanan Karthigeyan , Aravind Sekar , Harsimran Kaur , Pravin Salunke","doi":"10.1016/j.mycmed.2025.101569","DOIUrl":null,"url":null,"abstract":"<div><div>Pediatric isolated central nervous system (CNS) mould infections are uncommon but potentially fatal if not promptly diagnosed and treated. Such invasive lesions usually present as abscesses in parenchymal locations. Although the newer azole antifungals have shown improved outcomes, treatment data are limited in the pediatric age group, especially in young children. We report a case of a very young child with an unusual location of mould infection, in the temporal horn of the lateral ventricle, managed successfully. The 2-year-old-male child with prior COVID-19 infection and no other apparent immune dysfunction presented with features of raised intracranial pressure. CT/MRI imaging demonstrated a left temporal horn cystic lesion. Following an initial non-diagnostic aspiration of the cyst contents, the child underwent excision of the lesion. The potassium hydroxide stain of the content revealed hyaline septate hyphae, but the fungal culture was sterile. Histopathology of the specimen was highly suggestive of aspergillosis. The child was adequately treated with voriconazole, and had excellent clinical outcome at 22-month follow up. Rarely, CNS mould infection can manifest as an intraventricular space occupying lesion in children. Such a differential must be borne in mind. In our case, the infection was possibly a COVID-19 sequelae. The case also highlights the potential for successful clinical outcomes with an early and aggressive voriconazole treatment in pediatric intracranial mould infections, most likely aspergillosis.</div></div>","PeriodicalId":14824,"journal":{"name":"Journal de mycologie medicale","volume":"35 3","pages":"Article 101569"},"PeriodicalIF":1.8000,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Intraventricular mould infection suggestive of Aspergillosis in a 2-year-old child with successful clinical outcomes\",\"authors\":\"HCV Tulasi Ram , Madhivanan Karthigeyan , Aravind Sekar , Harsimran Kaur , Pravin Salunke\",\"doi\":\"10.1016/j.mycmed.2025.101569\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Pediatric isolated central nervous system (CNS) mould infections are uncommon but potentially fatal if not promptly diagnosed and treated. Such invasive lesions usually present as abscesses in parenchymal locations. Although the newer azole antifungals have shown improved outcomes, treatment data are limited in the pediatric age group, especially in young children. We report a case of a very young child with an unusual location of mould infection, in the temporal horn of the lateral ventricle, managed successfully. The 2-year-old-male child with prior COVID-19 infection and no other apparent immune dysfunction presented with features of raised intracranial pressure. CT/MRI imaging demonstrated a left temporal horn cystic lesion. Following an initial non-diagnostic aspiration of the cyst contents, the child underwent excision of the lesion. The potassium hydroxide stain of the content revealed hyaline septate hyphae, but the fungal culture was sterile. Histopathology of the specimen was highly suggestive of aspergillosis. The child was adequately treated with voriconazole, and had excellent clinical outcome at 22-month follow up. Rarely, CNS mould infection can manifest as an intraventricular space occupying lesion in children. Such a differential must be borne in mind. In our case, the infection was possibly a COVID-19 sequelae. The case also highlights the potential for successful clinical outcomes with an early and aggressive voriconazole treatment in pediatric intracranial mould infections, most likely aspergillosis.</div></div>\",\"PeriodicalId\":14824,\"journal\":{\"name\":\"Journal de mycologie medicale\",\"volume\":\"35 3\",\"pages\":\"Article 101569\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-06-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal de mycologie medicale\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1156523325000320\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MYCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal de mycologie medicale","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1156523325000320","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MYCOLOGY","Score":null,"Total":0}
Intraventricular mould infection suggestive of Aspergillosis in a 2-year-old child with successful clinical outcomes
Pediatric isolated central nervous system (CNS) mould infections are uncommon but potentially fatal if not promptly diagnosed and treated. Such invasive lesions usually present as abscesses in parenchymal locations. Although the newer azole antifungals have shown improved outcomes, treatment data are limited in the pediatric age group, especially in young children. We report a case of a very young child with an unusual location of mould infection, in the temporal horn of the lateral ventricle, managed successfully. The 2-year-old-male child with prior COVID-19 infection and no other apparent immune dysfunction presented with features of raised intracranial pressure. CT/MRI imaging demonstrated a left temporal horn cystic lesion. Following an initial non-diagnostic aspiration of the cyst contents, the child underwent excision of the lesion. The potassium hydroxide stain of the content revealed hyaline septate hyphae, but the fungal culture was sterile. Histopathology of the specimen was highly suggestive of aspergillosis. The child was adequately treated with voriconazole, and had excellent clinical outcome at 22-month follow up. Rarely, CNS mould infection can manifest as an intraventricular space occupying lesion in children. Such a differential must be borne in mind. In our case, the infection was possibly a COVID-19 sequelae. The case also highlights the potential for successful clinical outcomes with an early and aggressive voriconazole treatment in pediatric intracranial mould infections, most likely aspergillosis.
期刊介绍:
The Journal de Mycologie Medicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology. The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses. Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity.
JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered.
Under no circumstances does the journal guarantee publication before the editorial board makes its final decision.
The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.